Atlas Trials

Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT

Clinical trial NCT06306989 · UNKNOWN

Trial details

NCT number
NCT06306989
Sponsor
Cao Weijie
Status
UNKNOWN
Study type
OBSERVATIONAL
Letemovir for the Prevention of CMV Infection After Allo-HSCT
Start date
2023-01-01
Primary completion
2024-09-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.